Ethical Drug Market – Competition Strategies 2013-2014

Language:
Japanese
Product Code No:
C55118200
Issued In:
2013/09
#of Pages:
148
Publication Cycle:
  
Format:
PDF
Geographic Coverage:
Japan
Industry:

Price

120,000 yen ($776.30)
(excluding consumption tax)
240,000 yen ($1,552.59)
(excluding consumption tax)
360,000 yen ($2,328.89)
(excluding consumption tax)
* Equivalent value in US$ (Today's rate : $1= 154.58 yen , 2024/04/20 Japan)
*Scope of Each License Type

Coverage: (Product/service)

ethical drugs

Research Target:

manufacturers and wholesalers of ethical drugs

Research Content:

I   Current Competitive Status and Future Outlook of Ethical Drugs

  1. Ethical Drugs in Distructively Changes
  1. The Fair Trade Council of the Ethical Pharmaceutical Drugs Marketing Industry enhances regulations of business entertainment to MR Doctors
  2. Enhancement of regulations to MR visits at hospitals
  3. Doubts to data due to issues of large clinical studies
  4. Declining sales from MR
  5. A long-term listed items whose presence continues fading
  1. Another Filter for Drugs to be Used
  1. Polypharmacy causing Market Expansion
  2. No Progress in Reviewing of Polypharmacy in spite of Separation of Medical Practice and Drug Dispensation are Conducted
  1. Number of Outpatient Turned to a Decrease
  1. The growing tendency does not continue forever
  1. Existence of Pharmacy and Ethical Drugs
  1. Expansion of generic drugs and Pharmacists at Pharmacies
  1. Market Share and Profits Expansion
  1. Influence of go-on-the-market period to the market share and profits
  2. Marketing for expansion or maintaining of market share
  3. Factors necessary for selling new drugs
  1. Activities by MR after Enhanced Regulations of Business Entertainment
  1. Fading Existence of MR
  1. Deterioration in Rate to Achieve Agreemment due to three-rounds of negotiations for Determining Prices from Drug Wholesalers to Medical Facilities
  1. Drug Wholesalers are Sealing Price Competition which may aim for Expansion of Market Share
  2. If this status continues, the revision for charging of medicines may be far from actual cash value
  3. Unreaching agreement for long term may largely influence assessments to measures by drug wholesales
  4. Influence of Report on Japan Congress for Social Security System Reforms on Drug Prices from Drug Wholesalers to Medical Facilities
  1. Separation of Medical Practice and Drug Dispensation and Drug Sales
  1. Progress of separation of medical practice and drug dispensation that influenced power relatonships among drug wholesalers 
  2. Progress in pharmcies and drugs sales
  1. Marketing for Ethical Drugs
  1. Marketing under regulations
  2. The key is local areas in medical marketing
  3. Sales activities under enhancement of regulations
  4. Expanding sales areas may weaken sales abilities
  5. Rffectiveness of Share of Voice
  6. Information volume and attention
  7. Results depend on quality pursued by an MR
  8. Future of MR
  9. Providing information without using MR
  10. Is any efforts done for strengthening of relationship with Medical services?
  11. Presentation Effects by MR at drug wholesalers
  1. How to Foster Strong Competitiveness in Drug Sales?

II   Medical Services and Increasing Consumption Tax

  1. Basic Structure of Consumption Tax
  1. What is the consumption tax?
  2. 4 sections in tradings of consumption tax
  3. Reason why medical services have been defined as nontaxable transactions
  4. How the consumption tax works in medical facilities and dispensing pharmacies
  1. Consumption Tax Issue regarding Medical Services may Continue
  1. Amounts of consumption tax payment by medical facilities and dispensing pharmacies
  2. Influence of consumption tax payment to medical facilities and dispensing pharmacies
  3. What brings out by increase of consumption taxes to pharmaceutical and medical wholesaling industries
  1. Issues and Measurement on Future Increase of Consumption Tax Payment
  1. Changes to Medical Treatment Fees from nontaxable to taxable
  2. Points to keep in mind when the medical fees turn to taxable
    (Viewpoints from patients, medical facilities and from the national government)
  3. Measurement in medical treatment fees and problems in consumption tax issues
  4. How to think of medicine prices at the time of increasing consumption tax
  5. How to support consumption tax in pharmaceutical deliveries
  1. Measures to handle consumption tax when it raises to 10%
  1. Consideration of alternative method to alleviate consumption tax payment
  2. How to refund in the nontaxable system
  1. All Difficulties for Medical Services are to be Overcome
  2. Pharmaceutical Deliveries and Consumption Tax Increase
  1. Increase of consumption tax can both lead to crisis and business opportunity for drug wholesaling
  2. Consumption tax is included in medicine charges
  3. There are differences in drug wholesaling
  4. Can they utilize Special Measures Law for Shifting Consumption Tax?

III  Sales of Main Products by Major Pharmaceutical Companies

20 enterprises

Price

written in Japanese
120,000 yen ($776.30)
(excluding consumption tax)
240,000 yen ($1,552.59)
(excluding consumption tax)
360,000 yen ($2,328.89)
(excluding consumption tax)
* Equivalent value in US$ (Today's rate : $1= 154.58 yen , 2024/04/20 Japan)
*Scope of Each License Type